• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 03/31/15

    • 30-Day SEC Yield1

      1.08%
    • Total Net Assets

      $339.6M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.42%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      06/30/2015
  • Portfolio Composition (%)
    as of 03/31/15

    • % of Net Assets
    • Stocks

      99.55
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.45
  • Download All HoldingsAll Holdings (%) as of 03/31/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Novartis Ag
    NVS US
    320,157
    31,570,6829.30
    Johnson & Johnson
    JNJ US
    287,403
    28,912,7428.51
    Pfizer Inc
    PFE US
    671,649
    23,366,6696.88
    Novo Nordisk A/S
    NVO US
    354,897
    18,947,9515.58
    Sanofi
    SNY US
    347,940
    17,202,1545.06
    Merck & Co Inc
    MRK US
    291,274
    16,742,4304.93
    Actavis Plc
    ACT US
    55,756
    16,594,1014.89
    Glaxosmithkline Plc
    GSK US
    357,852
    16,514,8704.86
    Astrazeneca Plc
    AZN US
    228,056
    15,605,8724.59
    Eli Lilly & Co
    LLY US
    214,664
    15,595,3404.59
    Abbvie Inc
    ABBV US
    259,554
    15,194,2914.47
    Valeant Pharmaceuticals International I
    VRX US
    75,866
    15,068,5054.44
    Abbott Laboratories
    ABT US
    317,407
    14,705,4664.33
    Bristol-Myers Squibb Co
    BMY US
    224,023
    14,449,4844.25
    Teva Pharmaceutical Industries Ltd
    TEVA US
    229,892
    14,322,2724.22
    Shire Plc
    SHPG US
    55,646
    13,315,5313.92
    Mckesson Corp
    MCK US
    55,258
    12,499,3603.68
    Mylan Inc/Pa
    MYL US
    115,903
    6,878,8432.03
    Perrigo Co
    PRGO US
    39,821
    6,592,3671.94
    Amerisourcebergen Corp
    ABC US
    57,827
    6,573,1951.94
    Zoetis Inc
    ZTS US
    118,845
    5,501,3351.62
    Mallinckrodt Plc
    MNK US
    27,264
    3,452,9861.02
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    38,087
    3,416,4041.01
    Hospira Inc
    HSP US
    31,704
    2,784,8790.82
    Salix Pharmaceuticals Ltd
    SLXP US
    13,368
    2,310,1240.68
    Other/Cash
    1,529,0610.45
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.